Investigation of The Frequency of Thyroid Antibodies and Insulin Resistance in Early Stage Chronic Lymphocytic Leukemia
Abstract
Objectives: Chronic lymphocytic leukemia is the most common type of leukemia seen in adults worldwide. Hashimoto’s thyroiditis is the most common form of autoimmune thyroid disease. Usually, there are high levels of thyroglobulin antibodies or thyroid peroxidase antibodies. Metabolic syndrome is also very common in the world and has become a public health problem threatening the world. Immune dysregulation in metabolic syndrome, chronic lymphocytic leukemia, and autoimmune thyroid diseases unites these diseases on a common denominator. Based on this common mechanism, we aimed to investigate the frequency of insulin resistance and thyroid autoantibodies in patients with early-stage chronic lymphocytic leukemia.
Materials and Methods: Sixty-five early-stage chronic lymphocytic leukemia patients and 68 healthy controls were included in the study. Thyroid stimulating hormone, thyroglobulin antibodies, thyroid peroxidase antibodies, fasting blood glucose and fasting insulin levels were measured in the patients and control groups. Statistical evaluation was performed using the Statistical Package for Social Sciences (SPSS) for Windows 20 (IBM SPSS Inc., Chicago, IL) program. The normal distribution of the data was evaluated with the Kolmogorov-Smirnov test. Normally distributed numerical variables were shown as mean ± standard deviation, while numerical variables not showing normal distribution were shown as median (minimum,maximum). P<0.05 (*) value was considered significant in statistical analysis.
Results: Demographic and laboratory findings did not differ significantly between patients with chronic lymphocytic leukemia and those without thyroid dysfunction. The ratio of insulin resistance, thyroid dysfunction and thyroid antibodies in chronic lymphocytic leukemia and control groups did not differ significantly (p>0.05).
Conclusion:It was observed that the frequency of insulin resistance and thyroid antibodies in early-stage chronic lymphocytic leukemia was not different from healthy controls
Key Words: Chronic Lymphocytic Leukemia, Insulin Resistance, Thyroid Antibodies, Metabolic Syndrome
Keywords
Chronic Lymphocytic Leukemia, Insulin Resistance, Thyroid Antibodies, Metabolic Syndrome
References
- 1. Redaelli A, Laskin BL, Stephens JM, et al. The clinical and epidemiological burden of chronic lymphocytic leukaemia. Eur J Cancer Care (Engl).2004;13:279-287.
- 2. Kipps TJ, Stevenson FK, Wu CJ, et al. Chronic lymphocytic leukaemia. Nat Rev Dis Primers. 2017;3:16096.
- 3. Riches JC, Ramsay AG, Gribben JG. T-cell function in chronic lymphocytic leukaemia. Semin Cancer Biol. 2010;20:431-438.
- 4. Beyer M, Kochanek M, Darabi K, et al. Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood. 2005;106:2018-2025.
- 5. Giannopoulos K, Schmitt M, Kowal M, et al. Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia. Oncol Rep.2008;20:677-682.
- 6. Jadidi-Niaragh F, Ghalamfarsa G, Yousefi M, et al. Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions. Tumour Biol. 2013;34:2031-2039.
- 7. Lad DP, Varma S, Varma N, et al. Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias.Leuk Lymphoma. 2015;56:2424-2428.
- 8. Mao C, Wang S, Xiao Y, et al. Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves’ disease. J Immunol. 2011;186:4734-4743.
- 9. Glick AB, Wodzinski A, Fu P, et al. Impairment of regulatory T-cell function in autoimmune thyroid disease. Thyroid. 2013;23:871-878.
- 10. Raposo L, Martins S, Ferreira D, et al. Metabolic Syndrome, Thyroid Function and Autoimmunity - The PORMETS Study. Endocr Metab Immune Disord Drug Targets. 2019;19:75-83.